News
CLNNW
0.0540
0.00%
0.0000
Weekly Report: what happened at CLNNW last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at CLNNW last week (0408-0412)?
Weekly Report · 04/15 11:59
Weekly Report: what happened at CLNNW last week (0401-0405)?
Weekly Report · 04/08 12:05
Weekly Report: what happened at CLNNW last week (0325-0329)?
Weekly Report · 04/01 12:02
Weekly Report: what happened at CLNNW last week (0318-0322)?
Weekly Report · 03/25 12:06
Weekly Report: what happened at CLNNW last week (0311-0315)?
Weekly Report · 03/18 12:03
Clene Inc. reports results for the quarter ended in December - Earnings Summary
Clene Inc. Reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 6 cents per share. Revenue fell 27.4% to $170.00 thousand from a year ago. Clene Inc.'s shares had risen by 49.7% this quarter.
Reuters · 03/13 14:37
Clene: Current report
Press release · 03/13 14:02
Weekly Report: what happened at CLNNW last week (0304-0308)?
Weekly Report · 03/11 11:59
Weekly Report: what happened at CLNNW last week (0226-0301)?
Weekly Report · 03/04 12:02
Weekly Report: what happened at CLNNW last week (0219-0223)?
Weekly Report · 02/26 12:21
Weekly Report: what happened at CLNNW last week (0212-0216)?
Weekly Report · 02/19 12:23
Weekly Report: what happened at CLNNW last week (0205-0209)?
Weekly Report · 02/12 12:09
Weekly Report: what happened at CLNNW last week (0129-0202)?
Weekly Report · 02/05 12:22
Weekly Report: what happened at CLNNW last week (0122-0126)?
Weekly Report · 01/29 12:04
Weekly Report: what happened at CLNNW last week (0115-0119)?
Weekly Report · 01/22 12:10
Weekly Report: what happened at CLNNW last week (0108-0112)?
Weekly Report · 01/15 12:05
Clene: Current report
Press release · 01/08 16:03
Weekly Report: what happened at CLNNW last week (0101-0105)?
Weekly Report · 01/08 12:11
Weekly Report: what happened at CLNNW last week (1225-1229)?
Weekly Report · 01/01 12:03
More
Webull provides a variety of real-time CLNNW stock news. You can receive the latest news about Clene through multiple platforms. This information may help you make smarter investment decisions.
About CLNNW
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. It specializes in the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its CNM-Au8 is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide pathway while reducing oxidative stress. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for treatment of infectious diseases and to support wound healing.